These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


746 related items for PubMed ID: 25856297

  • 1. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
    Sun Y, Zhang T, Wang C, Jin X, Jia C, Yu S, Chen J.
    PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
    [Abstract] [Full Text] [Related]

  • 2. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J.
    J Exp Clin Cancer Res; 2018 Jul 03; 37(1):130. PubMed ID: 29970191
    [Abstract] [Full Text] [Related]

  • 3. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
    Mou T, Xie F, Zhong P, Hua H, Lai L, Yang Q, Wang J.
    Biomed Pharmacother; 2019 Mar 03; 111():891-900. PubMed ID: 30841468
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway.
    Zhou L, Jiao X, Peng X, Yao X, Liu L, Zhang L.
    J Cell Physiol; 2020 Nov 03; 235(11):8141-8154. PubMed ID: 31957029
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
    He D, Miao H, Xu Y, Xiong L, Wang Y, Xiang H, Zhang H, Zhang Z.
    PLoS One; 2014 Nov 03; 9(11):e112930. PubMed ID: 25411783
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
    Okazaki J, Tanahashi T, Sato Y, Miyoshi J, Nakagawa T, Kimura T, Miyamoto H, Fujino Y, Nakamura F, Takehara M, Ma B, Bando M, Kitamura S, Okamoto K, Muguruma N, Sogabe M, Takayama T.
    Digestion; 2020 Nov 03; 101(6):794-806. PubMed ID: 31563901
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.
    Xu RL, He W, Tang J, Guo W, Zhuang P, Wang CQ, Fu WM, Zhang JF.
    Exp Cell Res; 2018 Feb 15; 363(2):310-314. PubMed ID: 29366808
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y, Liu Z, Gou S.
    Oncotarget; 2016 Mar 22; 7(12):14912-24. PubMed ID: 26908446
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J.
    Carcinogenesis; 2010 Oct 22; 31(10):1726-33. PubMed ID: 20675343
    [Abstract] [Full Text] [Related]

  • 20. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
    Chen Z, Ma Y, Pan Y, Zhu H, Yu C, Sun C.
    Mol Cell Probes; 2018 Aug 22; 40():19-26. PubMed ID: 29908229
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.